CGuard Prime FDA Approval Puts InspireMD Mesh Stent Into TCAR After Recall Setback
InspireMD wins FDA approval for CGuard Prime in TCAR, backed by a 50-patient trial with zero strokes at 30 days. What the mesh stent adds and what remains unproven.
InspireMD wins FDA approval for CGuard Prime in TCAR, backed by a 50-patient trial with zero strokes at 30 days. What the mesh stent adds and what remains unproven.
FDA approved Contego Medical's Neuroguard IEP Direct for TCAR-IEP after PERFORMANCE III showed no strokes at 30 days in 146 patients.